Accumulation of Trehalose 6-Phosphate in Candidozyma auris results in Decreased Echinocandin Resistance and Tolerance Authors: Qingjuan Zhu, Sien Van de Velde, Stefanie Wijnants, Hans Carolus, Stef Jacobs, Dimitrios Sofras, Paul Vandecruys, Odessa Van Goethem, Regina Feil, Rudy Vergauwen, Wouter Van Genechten, Wim Van den Ende, Jeffrey M Rybak, Uwe Himmelreich, John E Lunn, Patrick Van Dijck Published: 2025 ABSTRACT AbstractCandidozyma auris is an emerging multidrug-resistant fungal pathogen that poses a major public-health challenge owing to high mortality and the limited efficacy of current therapies. Echinocandins, which inhibit β-glucan synthesis, are first-line therapy for invasive C. auris infection; however, resistance to this class is rising, underscoring the urgent need for new antifungal targets. Here we show that enzymes in the trehalose-biosynthetic pathway regulate stress responses, antifungal resistance/tolerance and virulence in C. auris. The tps2Δ strain displays heightened susceptibility to echinocandins, whereas tps1Δ and tps1Δ tps2Δ strains show resistance and tolerance comparable to wild type (WT). Mechanistically, the tps2Δ strain accumulates trehalose 6-phosphate (T6P), which inhibits hexokinase activity and reduces the flux of glucose 6-phosphate (G6P) into the chitin biosynthesis pathway, leading to substantially decreased cell wall chitin. During echinocandin exposure, the tps2Δ strain fails to compensate for reduced β-glucan with increased chitin, thereby rendering it highly susceptible to these drugs. In a systemic mouse infection model, deletion of the TPS2 gene results in lower tissue fungal burdens after treatment with caspofungin. Together, these findings identify Tps2 as a potential therapeutic target that can potentiate echinocandin efficacy in C. auris via a distinct mechanism of action.Subject terms: Fungal infection, Fungal biology, Antimicrobial resistance, Antifungal agents Introduction Candidozyma auris is an emerging opportunistic pathogen known for its ability to colonize the skin and cause life-threatening systemic infections, particularly in hospitalized patients with underlying health conditions, including those affected by COVID-191,2. What makes C. auris particularly concerning is its frequent resistance to multiple classes of antifungal drugs, including azoles, polyenes, and echinocandins, which significantly complicates treatment3,4. Studies have shown that up to 90% of C. auris isolates exhibit resistance to fluconazole, 50% to amphotericin B, and 5% to echinocandins5,6. In vivo studies indicate that micafungin, an echinocandin, is more effective in treating invasive C. auris infections compared to fluconazole or amphotericin B7. However, the widespread use of these echinocandins has raised concerns about the potential development of resistance and tolerance to this critical class of antifungal drugs8–11. Here, resistance is considered as a decrease in susceptibility—i.e., an increased MIC relative to a control or clinical breakpoint—caused by stable genetic changes that alter the drug target and/or intracellular drug concentration. In contrast, tolerance is the ability of an otherwise drug-susceptible isolate to survive and grow slowly at concentrations above the MIC without a change in MIC. Tolerance reflects phenotypic heterogeneity and is typically mediated by central stress-response pathways12. During infection, C. auris faces numerous stressors, including temperature fluctuations, nutrient and osmolarity changes, and hypoxic or oxidative stress, all of which can impact its survival and virulence13–15. The yeast must efficiently mobilize its energy reserves and protect its proteins against these damaging insults. Notably, the disaccharide trehalose has been implicated in providing protection against these stresses, playing a crucial role in the survival mechanisms of yeast under hostile conditions. Understanding the molecular basis of these protective strategies in C. auris is essential for developing new therapeutic approaches to combat this formidable pathogen16–18. Trehalose (α-D-glucopyranosyl-(1 → 1)-α-D-glucopyranoside) is a non-reducing disaccharide composed of two glucose molecules linked by an α,α−1,1-glycosidic bond and is synthesized by a wide range of organisms, including bacteria, fungi, plants, and invertebrates17,19. However, trehalose is notably absent in mammals. In pathogenic fungi, trehalose plays a critical role in cellular protection and stabilizing membranes under various stress conditions encountered during infection, including oxidative stress, osmotic stress and heat shock11. In addition, the protective effects of trehalose are also attributed to its ability to stabilize proteins by preventing their denaturation and aggregation20–23. Moreover, trehalose aids in the reactivation of denatured proteins by facilitating their interaction with molecular chaperones, such as heat shock proteins24. In addition to its protective functions, trehalose has been proposed to act as a reserve carbon source25. The biosynthesis of trehalose is governed by a two-step enzymatic pathway26. The first enzyme, Tps1, catalyzes the conversion of uridine diphosphate glucose (UDPG) and glucose 6-phosphate (G6P) into trehalose 6-phosphate (T6P). This T6P has been implicated in the regulation of hexokinase II, which in turn influences glycolytic flux in fungi27–29. In the next step, the second enzyme, Tps2, removes the phosphate group from T6P to produce trehalose. This biosynthetic pathway is absent in humans, making it an attractive target for the development of novel antifungal therapies25,30. Targeting the trehalose biosynthesis pathway in fungi could disrupt key stress responses and virulence mechanisms25, thereby providing a means for combating fungal infections with potentially minimal off-target effects in humans. In this study, we investigated the role of the trehalose biosynthesis pathway in drug resistance and pathogenicity of C. auris. Our findings highlight the importance of trehalose biosynthetic enzymes in supporting fungal growth under thermal stress and in modulating antifungal drug responses. We found that the accumulation of T6P plays a critical role in inhibiting hexokinase activity, thereby reducing glycolytic flux and impairing cell wall biosynthesis. This disruption compromises the cell’s ability to compensate for echinocandin-induced cell wall damage, leading to decreased antifungal resistance and tolerance. These findings highlight Tps2 as a promising target for antifungal drug development. Results Tps2 is important for heat and cell wall stress in C. auris To assess the role of the trehalose biosynthesis pathway during growth of C. auris, we generated single-gene deletion mutants of TPS1 (tps1Δ) and TPS2 (tps2Δ), as well as a double mutant (tps1Δ tps2Δ), in the clade I reference strain B8441. Growth curve assays were performed in RPMI 1640 medium supplemented with either 0.2% or 2% glucose. Unlike what has been observed in other yeast species31–33, disruption of the trehalose biosynthesis pathway in a C. auris clade I strain did not impact growth under physiological glucose concentrations, as all mutant strains (tps1Δ, tps2Δ, and tps1Δ tps2Δ) exhibited growth profiles comparable to the WT strain under both glucose concentrations (Fig. 1A). These results highlight a distinct metabolic feature of C. auris and indicate that trehalose biosynthesis is not essential for its glucose metabolism or overall growth under these tested conditions. Growth and stress resistance phenotypes of C. auris trehalose pathway mutants. A Growth curves of WT (B8441 clade I), tps1Δ, tps2Δ, and tps1Δ tps2Δ strains in liquid RPMI 1640 medium supplemented with 0.2% and 2% glucose at 37 °C. Optical density at 600 nm was measured over 48 hours. The “-1, -2, -3” labels represent independent transformations. B Growth evaluation after 48 h on RPMI 1640 medium at 37 °C, 39 °C, and 42 °C. Color and symbol legends for different strains are given in (A). C BDA depicts the relative growth as a function of stressor concentration in RPMI 1640 (pH 7, 2% glucose) after 48 h of incubation. The stress-inducing compounds used were CFW, CR, SDS, NaCl and H2O2. Color and symbol legends for different strains are given in (A). D Heatmap that represents the RRAUC of the deletion strains for the same stressors, compared to the WT strain. The color scale determines the difference in RRAUC between the deletion strains and the WT strain. This calculated value is depicted on the heatmap. Data presented in (A–D) are expressed as mean ± SEM (standard error of the mean) from two (C, D) or three (A, B) independent experiments using three independent transformants of each strain, with two technical replicates per experiment. Source data are provided as a Source Data file. Given the established role of trehalose in mediating environmental stress responses, we evaluated the growth and stress susceptibility of the trehalose biosynthesis-deficient strains under various conditions. To assess thermal stress tolerance, growth assays were conducted at 37, 39, and 42 °C. All mutant strains exhibited varying degrees of growth inhibition, with the tps2Δ strain exhibiting the most severe defect. Specifically, tps2Δ displayed impaired growth at 39 °C and completely failed to grow at 42 °C, indicating a marked loss of high-temperature tolerance (Fig. 1B). In contrast, although the tps1Δ and tps1Δ tps2Δ strains also exhibited reduced growth relative to the WT at 42 °C, their growth was less affected than that of the tps2Δ strain. These results suggest that trehalose synthesis plays a critical role in maintaining thermal stress tolerance in C. auris. To evaluate stress resistance, the mutant and WT strains were tested against oxidative stress (hydrogen peroxide, H₂O₂), osmotic stress (sodium chloride, NaCl), membrane stress (sodium dodecyl sulfate, SDS), and cell wall stress (calcofluor white, CFW, and Congo red, CR). No significant differences were detected between the WT and mutant strains under oxidative, osmotic, or membrane stress conditions (Fig. 1C). In contrast, clear differences emerged under cell wall stress. The tps2Δ strain showed increased sensitivity to CFW, a chitin-binding dye, but exhibited enhanced resistance to CR, which binds to β-glucan in the cell wall. By comparison, tps1Δ and tps1Δ tps2Δ strains did not display significant differences in sensitivity to either CFW or CR relative to the WT strain (Fig. 1C). To quantitatively assess stress resistance, we calculated the area under the growth curve (AUC) for each condition and normalized these values to the WT strain to obtain relative resistance values (RRAUC), with the WT defined as 1. Values above 1 indicate greater resistance than WT, while values below 1 indicate reduced resistance. The relative ratios (RR) of AUC were calculated in Eq. 1: These values are summarized in a heatmap (Fig. 1D). The tps2Δ strain exhibited reduced resistance to CFW and H₂O₂, but increased resistance to CR compared with the WT strain. In contrast, both tps1Δ and tps1Δ tps2Δ strains showed decreased resistance to both CFW and CR relative to the WT strain. To confirm that the observed phenotypes were attributable to loss of the TPS2 gene, we complemented the tps2Δ strain to generate a TPS2-reintegrant strain (tps2Δ+TPS2). Complementation restored the stress-associated growth phenotypes: thermotolerance returned to WT levels, and resistance to the cell wall stressors CFW and CR was largely indistinguishable from the WT strain (Supplementary Fig. S1). Tps2 plays a role in echinocandin resistance and tolerance Given the trehalose biosynthetic pathway is involved in cell wall stress response, we investigated its contribution to resistance against clinically relevant antifungal drugs, which target either the fungal cell membrane (azoles and polyenes) or the cell wall (echinocandins). We conducted drug broth microdilution assays (BDA) (Fig. 2A, B) and ETEST® assays (Fig. 2C) to determine resistance and tolerance towards these drugs. Antifungal susceptibility testing (AFST) of WT and mutant strains. A BDA for caspofungin, micafungin, anidulafungin, amphotericin B and fluconazole for the WT (B8441 clade I), tps1Δ, tps2Δ and tps1Δ tps2Δ strains. The lowest concentration that inhibits growth by 50% or more is generally considered the MIC, clinical breakpoints refer to MIC values above which isolates are considered to be resistant. B Heatmap that represents the RRAUC of the deletion strains for antifungal drugs, compared to the WT strain. The color scale determines the difference in RRAUC between the deletion strains and the WT strain. This calculated value is depicted on the heatmap. C Etest analysis at 37 °C (48 h) showing an inhibition ellipse in regions of the medium with high concentrations of antifungal drugs, where the cells are unable to grow. The MIC value (in µg/mL) is read as the lowest concentration at which the border of the elliptical growth inhibition zone intercepted the strip, and is indicated in the top-right corner of each image. E-test strip® assays provide a visual approximation of tolerance as the proportion of growth within the zone of inhibition relative to growth outside it. Data presented in (A, B) indicate as mean ± SEM from two independent experiments using three independent transformants of each strain, with three technical replicates per experiment. Source data are provided as a Source Data file. In this context, reduced relative resistance is interpreted as increased susceptibility compared with the WT strain, while tolerance refers to the ability of a subpopulation of cells to grow slowly but persistently at drug concentrations above the minimum inhibitory concentrations (MICs). Together, these assays allowed us to evaluate both resistance and tolerance phenotypes in the trehalose-deficient mutants. Results from the BDAs revealed that deletion of the TPS2 gene significantly reduced resistance and tolerance to all three echinocandins (caspofungin, micafungin, and anidulafungin). This is evident from respectively lower MIC and reduced growth at concentrations above the MIC (supra-MIC growth), quantified by lower AUC of the BDA (Fig. 2A). RRAUC calculated from the growth curves serve as an indicator of drug tolerance, which is visualized in the heatmap (Fig. 2B). The tps2Δ strain displayed a complete loss of tolerance to all three echinocandins and slightly increased tolerance to fluconazole. Meanwhile, the tps1Δ and tps1Δ tps2Δ strains showed a slight increase in tolerance to amphotericin B. Consistent with the phenotypic observations, Etest analysis demonstrated a clear reduction in echinocandin resistance and tolerance in the tps2Δ strain compared to the WT. The MIC values for all three echinocandins were lower in the tps2Δ strain than in the WT, indicating increased susceptibility. The specific MIC values are shown in the upper right corner of each Etest. Furthermore, the tps2Δ strain exhibited minimal to no growth within the inhibition elipse after 48 h, reflecting a complete loss of echinocandin tolerance (Fig. 2C). In contrast, no significant differences in susceptibility or tolerance to amphotericin B or fluconazole were observed between the tps2Δ and WT strains. To further establish that the phenotype stems from TPS2 gene loss, we assessed caspofungin susceptibility and tolerance in the TPS2 reintegrant strain (tps2Δ+TPS2) using BDA and Etest assays (Supplementary Fig. S2). Complementation restored WT behavior: the caspofungin MIC of tps2Δ + TPS2 matched WT, and supra-MIC growth was likewise comparable. These results confirm that the heightened echinocandin sensitivity of the tps2Δ strain is due to TPS2 gene deficiency. T6P accumulation in the tps2Δ strain is independent of caspofungin treatment To investigate whether intracellular levels of trehalose and T6P influence echinocandin resistance and tolerance in C. auris, we quantified these metabolites in exponentially growing cells, both in the presence and absence of caspofungin (Fig. 3A, B). In unstressed conditions, deletion of the TPS2 gene led to a substantial accumulation of T6P, reaching levels nearly 300-fold higher than those observed in the WT strain. Conversely, deletion of the TPS1 gene, either alone or in combination with the TPS2 gene, resulted in a complete loss of detectable trehalose or T6P. Interestingly, deletion of the TPS2 gene alone still results in low accumulation of a small, residual amount of trehalose, similar to what is observed in C. albicans and C. glabrata31. Intracellular T6P and trehalose concentrations in response to caspofungin exposure. A Quantification of intracellular T6P levels in exponentially growing cells treated with or without caspofungin (CAS) for 60 min. B Quantification of intracellular trehalose levels under the same experimental conditions (ww, wet weight). Data presented in (A, B) are expressed as mean ± SEM from three independent experiments using three independent transformants of each strain, with three technical replicates per experiment. Statistical significance analysis was performed using two-way ANOVA with Bonferroni correction. Source data are provided as a Source Data file. To assess whether trehalose or T6P levels respond to echinocandin stress, exponentially growing cells were treated with caspofungin at ten times MIC (2.5 µg/mL) for 60 min. However, no significant changes in trehalose or T6P levels were observed in either the WT or mutant strains following treatment (Fig. 3A, B). It is interesting to note that in the WT under normal conditions, there is already a high amount of trehalose produced. This is different to e.g., the situation in S. cerevisiae, where in exponentially grown cells, there is nearly no accumulation of trehalose34. This difference may be responsible for the intrinsically very high stress tolerance of C. auris. Tps2 exhibits conserved roles across distinct C. auris clades To assess whether the role of the trehalose synthesis pathway is conserved across different clades of C. auris, we performed a phylogenetic analysis of the Tps2 proteins (Fig. 4A), which revealed that Tps2 is highly conserved across all five C. auris clades, with minimal sequence divergence. To further investigate the functional conservation of the TPS2 gene, we generated TPS2 gene deletion strains in representative strains from Clade III (B11221), Clade IV (B11244), and Clade V (IFRC2087). Clade II was excluded from this analysis, given that Clade II strains are rarely associated with systemic infections and echinocandin treatment35. Functional roles of the TPS2 gene across C. auris clades. A Phylogenetic analysis of Tps2 orthologs across C. albicans, C. haemulonii, C. pseudohaemulonii, C. duobushaemulonii and five C. auris clades. B BDA assay showing the drug (caspofungin, micafungin and anidulafungin) susceptibility and stress (SDS, CFW and CR) susceptibility of clade I WT, clade I tps2Δ, clade III WT, clade III tps2Δ, clade IV WT, clade IV tps2Δ, clade V WT, and clade V tps2Δ strains. C Heatmap that represents the RRAUC of the deletion strains for the same stressors, compared to the WT strain. The color scale determines the difference in RRAUC between the deletion strains and the WT strain. This calculated value is depicted on the heatmap. Data presented in (B, C) are expressed as mean ± SEM from n = 3 independent experiments using one independent transformant of each strain, with three technical replicates per experiment. Source data are provided as a Source Data file. The resulting tps2Δ strains from different C. auris clades were analyzed using drug and stress BDAs to assess their responses to diverse antifungal treatments and environmental stresses. From the drug BDA assay (Fig. 4B), all tps2Δ strains exhibited reduced MIC50 values for three echinocandins compared to their respective WT strain. The stress-response phenotypes observed in these tps2Δ strains were also largely consistent with those observed for the Clade I strain B8441. Specifically, deletion of the TPS2 gene resulted in increased sensitivity to CFW and enhanced resistance to CR, indicating alterations in cell wall stress responses. To further quantify differences in stress and drug tolerance, relative resistance was assessed by calculating the area under the curve (RRAUC) for each condition (Fig. 4C). Across all clades, tps2Δ strains showed a marked reduction in RRAUC values for echinocandins. For CR stress, RRAUC values increased in all tps2Δ strains, while under CFW stress, RRAUC values decreased, further supporting a shift in cell wall composition and stress response. These findings demonstrate that the function of Tps2 in supporting echinocandin resistance and tolerance and maintaining cell wall integrity is conserved across multiple C. auris clades. Deletion of the TPS2 gene results in impaired chitin biosynthesis To investigate the mechanism underlying the increased echinocandin susceptibility of the tps2Δ strain, we compared cell-wall composition in the WT Clade I isolate B8441 and the corresponding panel of Clade I mutant strains. Confocal microscopy was performed to visualize specific components of the cell wall, employing CFW to detect chitin, Alexa Fluor 488–conjugated antibodies to stain β-glucans, and Concanavalin A–Alexa Fluor 488 to visualize mannans (Fig. 5A). The confocal microscopy images revealed significantly reduced CFW staining intensity in the tps2Δ strain. In contrast, no significant differences in outer cell membrane mannan and β-glucan levels were detected between the tps2Δ and WT strains. The cell wall stainings of tps1Δ and tps1Δ tps2Δ strains showed no notable differences compared to WT cells, indicating no significant alterations in chitin, β-glucan, or mannan content. Deletion of the TPS2 gene results in reduced chitin content in the C. auris cell wall. A Confocal microscopy of cell wall components in C. auris Clade I isolate B8441 and the corresponding panel of Clade I mutant strains. Triple-staining of chitin, β-glucans and mannans, fluorescently labeled with CFW, Alexa Fluor 488 and Concanavalin A-Alexa fluor 488 antibodies, respectively. Differential Interface Contrast (DIC) and fluorescent pictures are shown. Higher fluorescent color intensity reflects an increase in the respective cell wall component. Laser exposure time was kept constant for each individual species. Images were processed using Fiji macOS x86-64. Scale bars represent 10 µm. B Measurement of total cell-wall chitin, β-glucan, and mannan contents in C. auris cells as described in Materials and Methods. Y-axis labels are shown as µmol/mg wet weight (ww); values represent monosaccharide equivalents (chitin as glucosamine, β-glucan as glucose, and mannan as mannose equivalents) derived from standard curves. Data presented in B are expressed as mean ± SEM from n = 3 independent experiments using three independent transformants of each strain, with three technical replicates per experiment. Statistical analysis was conducted by one-way ANOVA with Bonferroni correction. Source data are provided as a Source Data file. To further substantiate the microscopy findings, we quantified the same three major cell wall components using high-performance liquid chromatography (HPLC). These data confirmed a significant reduction in chitin content in the tps2Δ strain compared to the WT (Fig. 5B). In contrast, mannan and β-glucan levels remained comparable across all strains. The observed reduction in chitin content in the tps2Δ strain prompted us to investigate basal expression levels of genes involved in fungal cell wall biosynthesis (Fig. 6A). To this end, we examined the expression of several putative chitin synthase genes (CHS1, CHS2, CHS3, and CHS8) (Fig. 6B), as well as the GFA1 gene (Fig. 6C), which encodes glutamine-fructose-6-phosphate amidotransferase—an enzyme catalyzing the initial step in the hexosamine biosynthetic pathway essential for chitin synthesis. In addition, we assessed the expression of genes encoding β-glucan synthases (FKS1 and FKS2) to comprehensively evaluate cell wall biosynthesis alterations in mutant strains (Fig. 6D). Basal expression levels of genes involved in fungal cell wall biosynthesis in WT and mutant strains. A Schematic of the biosynthetic pathways of chitin and β-(1,3) glucan in fungi. Created in BioRender. Van dijck, P. (2025) https://BioRender.com/jsisqtp. Transcript levels of (B) chitin synthase genes (CHS1, CHS2, CHS3, and CHS8), (C) glutamine-fructose-6-phosphate aminotransferase gene (GFA1), and (D) β-glucan synthase genes (FKS1 and FKS2) were quantified by qPCR from cells harvested at the exponential growth phase. Relative gene expression levels (B–D) are shown as mean ± SEM from n = 3 independent experiments, each including three independent transformants per strain, with three technical replicates per experiment. Values were normalized to the average expression in WT (B8441 clade I) samples. Statistical significance was assessed using one-way ANOVA with Bonferroni correction on log2-transformed data. Source data are provided as a Source Data file. Quantitative PCR (qRT-PCR) analysis revealed significant alterations, primarily within the chitin biosynthesis pathway. Notably, GFA1 expression was significantly increased in all mutant strains relative to the WT, underscoring a critical link between trehalose metabolism and chitin biosynthesis. Conversely, CHS1 and CHS2 genes expression levels were significantly decreased in the tps2Δ strain, while expression levels of CHS3 and CHS8 genes remained unchanged across all strains. Furthermore, expression of FKS1 and FKS2 genes showed no significant differences, suggesting that β-glucan synthesis was unaffected by TPS1 or TPS2 gene disruption. Collectively, these results are consistent with and support the observed reduction in chitin content specifically observed in the tps2Δ strain. Gfa1 is essential but does not account for the tps2Δ echinocandin susceptibility Gene expression assays revealed that GFA1 gene expression was upregulated in the tps2Δ strain. Based on this observation, we initially hypothesized that T6P accumulation in the tps2Δ background may directly alter the structure or enzymatic activity of Gfa1, thereby impairing chitin synthesis and compromising cell wall integrity, ultimately rendering the cells more susceptible to echinocandin-induced stress. To test this hypothesis, we generated a GFA1 gene knockout strain in the B8441 background and assessed its phenotype using BDA and Etest analysis. Growth curve analysis demonstrated that Gfa1 is essential for viability with glucose as a carbon source in C. auris, as deletion mutants were unable to grow in glucose-containing media (Fig. 7A). The restoration of growth upon supplementation with exogenous glucosamine confirmed that the growth defect was attributable to impaired hexosamine biosynthesis. Notably, when glucosamine was provided at a minimal concentration (10 mM) sufficient to support basal growth, the gfa1Δ strain exhibited substantially reduced resistance and tolerance to caspofungin (Fig. 7B, C). Increasing the concentration of glucosamine progressively improved both resistance and tolerance; however, full recovery to WT levels was not achieved. These findings indicate that the accumulation of T6P does not directly alter the structure or enzymatic function of Gfa1. GFA1 is essential for growth and modulates caspofungin susceptibility in C. auris. A Growth curves of WT (B8441 clade I) and gfa1Δ strains cultured in liquid RPMI 1640 medium supplemented with 2% glucose and varying concentrations of glucosamine (10, 30, and 50 mM) at 37 °C. Optical density at 600 nm was measured over a 48-hour period. B Broth dilution assay (BDA) evaluating caspofungin susceptibility in WT and gfa1Δ strains grown on RPMI 1640 supplemented with 2% glucose and increasing concentrations of glucosamine (10, 30, and 50 mM). C Etest analysis performed at 37 °C for 48 h on RPMI 1640 agar plates supplemented with 2% glucose and the indicated concentrations of glucosamine (10, 30, and 50 mM). The formation of inhibitory zones (“halos”) indicates areas of high antifungal concentration where cell growth is suppressed. Data presented in (A, B) are expressed as mean ± SEM from three independent experiments using one (B) or three (A) independent transformants of each strain, with two technical replicates per experiment. Source data are provided as a Source Data file. T6P accumulation indirectly reduces chitin production by inhibiting hexokinase activity To investigate how the deletion of the TPS2 gene affects the chitin synthesis pathway, we focused on the role of T6P, a known regulator of the initial steps of glycolysis in yeast, primarily through its inhibition of hexokinase II (Fig. 8A)36. To assess whether this is also the case for C. auris, we analyzed hexokinase enzymatic activity in WT and mutant strains. Both the tps1Δ and tps1Δ tps2Δ strains exhibited increased hexokinase activity, while deletion of the TPS2 gene resulted in a significant reduction in hexokinase activity compared to the WT strain (Fig. 8B). Complementation of TPS2 gene restored hexokinase activity to WT levels (Supplementary Fig. S3). T6P plays a role in glucose metabolism. A Schematic of glucose metabolism and its integration with trehalose biosynthesis, glycolysis, and cell wall precursor pathways in fungi. Created in BioRender. Van dijck, P. (2025) https://BioRender.com/. B Kinase activity on glucose. The cells were grown in RPMI 1640 medium with 100 mM glucose before proteins were isolated and kinase activity was measured. The values of the deletion strains are normalized relative to the WT (B8441 clade I) strain, which has 100% kinase activity. Data presented as mean ± SEM from three independent experiments using three independent transformants of each strain. Statistical analysis was done by using a one-way ANOVA test with Bonferroni correction. C–F ¹³C NMR spectral analysis of glucose utilization and metabolites in the studied strains after incubation with [1-¹³C]glucose at 37 °C. Quantification was based on ¹³C signal intensities relative to the initial glucose signal. The total signal from [1-¹³C]glucose at the first time point (t = 15 min) was set to 100%, and the NMR signals of downstream metabolites were expressed as a percentage of this initial reference signal. This relative quantification reflects ¹³C-label redistribution over time and does not represent absolute metabolite concentrations in the medium. ‘Relative Glucose Signal %’ referes to the relative ¹³C signal intensity (in %) of the initial alph + beta [1-¹³C] glucose signal for the relative quantification of glucose utilization and glycerol, mannitol and ethanol synthesis. Data presented as mean ± SEM from n = 3 independent experiments (different independent transformants of each strain), with one technical replicate per experiment. Source data are provided as a Source Data file. Considering that the trehalose biosynthesis pathway modulates glycolytic flux in various fungal species, we subsequently measured metabolites derived from glucose-dependent pathways. Therefore, 13C NMR spectroscopy was conducted to elucidate the interplay between glycolysis, trehalose metabolism, and chitin synthesis (Fig. 8C–F). The analysis revealed that the tps1Δ and tps1Δ tps2Δ strains exhibited an increased and quicker glucose consumption compared to the WT (Fig. 8C). This is similar to what is observed in S. cerevisiae, where a tps1∆ strain has a very high flux into glycolysis because of very high hexokinase activity. As a result of this higher influx in glycolysis, both the tps1∆ and tps1∆ tps2∆ strains produced ethanol at a higher rate compared to the WT (Fig. 8D), while glycerol and mannitol levels remained unchanged (Fig. 8E, F). In contrast, the tps2Δ strain exhibited a pronounced reduction in glucose consumption (Fig. 7C), accompanied by significantly lower levels of glycolysis-derived metabolites, including ethanol, glycerol, and mannitol. As a result, reduced carbon flow through glycolysis may limit the availability of F6P for downstream biosynthetic pathways. Given that UDP-N-acetylglucosamine (UDP-GlcNAc), the precursor for chitin synthesis, is derived from F6P, these findings also imply that chitin biosynthesis is compromised in the tps2Δ strain. This metabolic constraint likely explains the reduced chitin levels detected in the tps2Δ strain. 13C NMR spectroscopy also confirmed the synthesis of trehalose for the WT and accumulation of T6P for the tps2Δ strain (Supplementary Fig. S4). Exogenous glucosamine restores caspofungin resistance and tolerance in the tps2Δ strain To determine whether the reduced resistance and tolerance of the tps2Δ strain to echinocandins were directly attributable to T6P accumulation, resulting in impaired glycolytic flux and subsequently diminished chitin biosynthesis, we performed caspofungin susceptibility assays with varying concentrations of exogenous glucosamine to evaluate its potential to rescue the susceptibility phenotype. The results demonstrated a non-linear relationship between glucosamine concentration and caspofungin resistance. Specifically, the MIC values of the tps2Δ strain were approximately 0.125 µg/mL at 10 mM, 0.25 µg/mL at 20 mM, and 1 µg/mL at both 30 mM and 50 mM glucosamine. These data suggest that low to moderate levels of glucosamine partially restore caspofungin tolerance in the absence of the TPS2 gene (Fig. 9A). Exogenous glucosamine supplementation restore susceptibility to caspofungin. A Relative growth of the clade I tps2Δ strain during a BDA with varying caspofungin concentrations and different levels of exogenous glucosamine supplementation. B Etest analysis at 37 °C (48 h) showing an inhibition ellipse in regions of the medium with high concentrations of caspofungin, where the cells are unable to grow. The MIC value (in µg/mL) is read as the lowest concentration at which the border of the elliptical growth inhibition zone intercepted the strip, and is indicated in the top-right corner of each image. Data presented in A as mean ± SEM from n = 3 independent experiments using one independent transformants of each strain, with three technical replicates per experiment. Source data are provided as a Source Data file. Consistent with the BDA findings, Etest assays performed after 48 h confirmed that glucosamine supplementation improved caspofungin resistance and tolerance in the tps2Δ strain, but this improvement did not continue beyond 30 mM. At both 30 mM and 50 mM glucosamine, the tps2Δ strain exhibited similar capacity for growth within the inhibition ellipse (Fig. 9B). Together, these results suggest that while glucosamine can compensate to some extent for the loss of the TPS2 gene, its ability to enhance caspofungin resistance and tolerance is limited and does not increase indefinitely with concentration. Deletion of Tps2 sensitizes C. auris to caspofungin in a murine candidemia model Given the pronounced defects in echinocandin resistance and tolerance observed in the tps2Δ strain under in vitro conditions, we determined whether these phenotypes translated to differences in susceptibility in an in vivo context. To assess the impact of the tps2Δ strain on the in vivo susceptibility of C. auris to caspofungin, immunocompromised mice were intravenously infected with either the WT strain or the tps2Δ strain and subsequently treated with caspofungin or PBS. To assess the virulence of C. auris strains and the therapeutic impact of caspofungin, we measured fungal burden in the kidneys and brains of infected mice, as schematically depicted in Fig. 10A. To assess the health status of mice after infection and treatment, body weight was monitored daily from day 0 to day 6 (Fig. 10B). No significant differences in body weight were observed among the groups, regardless of infection with WT or tps2Δ strains, or treatment with PBS or caspofungin. Further, we found that in the absence of caspofungin treatment, both the WT and tps2Δ strains showed similar levels of fungal burden in these organs, indicating that deletion of the TPS2 gene does not impair the intrinsic virulence of C. auris. However, following caspofungin treatment, fungal burden in mice infected with the tps2Δ cells was significantly lower than in those infected with the WT strain in both kidneys and brains (Fig. 10C). This indicates that tps2Δ cells are less able to survive after caspofungin treatment in vivo. Together, these findings suggest that loss of the TPS2 gene leads to a complete loss of caspofungin tolerance under host conditions and that a combination therapy of echinocandin with a Tps2 inhibitor would be an effective combination therapy. Fungal burden in the target organs of mice infected with C. auris strains. A Schematic representation of the experiment processes for the mice infection model. CP: cyclophosphamide, IP: intraperitoneal, CAS: caspofungin, CFU: colony-forming unit. Created in BioRender. Van dijck, P. (2025) https://BioRender.com/13ot4bb. B Six-day body-weight trajectories of immunosuppressed mice (n = 6 per group) following infection with C. auris B8441 (WT) or tps2Δ and treatment with PBS or caspofungin (CAS). Body weight was recorded daily (mg). Data are indicated as mean ± SEM of six mices in one group. C Assessment of fungal burden in the kidneys and brains of immunosuppressed mice (n = 6) 6 days post-infection with WT or tps2Δ quantified using CFU counts. Data presented are expressed as mean log10(CFU/g) ± SEM from six infected mice. Statistical significance analysis was performed using two-way ANOVA with Bonferroni correction. Source data are provided as a Source Data file. Discussion This study elucidates the critical role of the trehalose biosynthesis pathway, particularly the accumulation of T6P, in modulating antifungal susceptibility and maintaining cell wall integrity in C. auris, an emerging multidrug-resistant pathogen that poses a significant threat in healthcare settings37. Our findings demonstrate that, although trehalose biosynthesis is not essential for basal glucose metabolism, it plays a pivotal role in thermal stress tolerance and in preserving the structural integrity of the fungal cell wall in C. auris. Notably, deletion of the TPS2 gene resulted in a pronounced increase in susceptibility to echinocandin antifungal agents in vitro. The enhanced echinocandin susceptibility of the tps2Δ strain is most consistent with metabolic dysregulation associated with intracellular T6P accumulation. T6P can modulate hexokinase activity and thereby influence the entry of sugars into glycolysis. Such changes would be expected to affect the supply of UDP-GlcNAc, the precursor for chitin synthesis38. In line with this, we observed reduced chitin content and increased GFA1 transcript abundance in the tps2Δ strain. The upregulation of GFA1 likely reflects a compensatory cell-wall stress response, similar to that reported in S. cerevisiae39, rather than direct inhibition of Gfa1 by T6P. Overall, our data support a model in which disruption of trehalose metabolism perturbs central carbon and cell-wall homeostasis, increasing echinocandin susceptibility. Targeted metabolomics and enzymatic assays will be required to test this mechanism. Our growth analysis revealed that a functional trehalose biosynthesis pathway is not essential for basal glucose metabolism, as deletion of neither TPS1 nor TPS2 genes did impair growth under standard conditions (37 °C) when glucose was used as the sole carbon source. Specifically, deletion of the TPS1 gene resulted in the complete absence of both trehalose and T6P. As expected, this led to enhanced glycolytic flux due to the loss of T6P-mediated inhibition of hexokinase activity. This finding contrasts sharply with observations in S. cerevisiae and C. glabrata, where deletion of the TPS1 gene causes severe growth impairments due to metabolic imbalance31,40. In S. cerevisiae, T6P functions not only as a glycolytic inhibitor but also as a key signaling molecule that regulates carbon flux and cellular proliferation41,42. The absence of T6P in tps1Δ strain leads to unregulated glucose uptake, accumulation of glycolytic intermediates, and ultimately growth defects when glucose is the primary carbon source26. Similar growth defects have been reported in C. glabrata31, indicating a conserved reliance on T6P-mediated metabolic regulation in these species. As far as we know, the only species where deletion of the TPS1 gene did not affect growth on glucose is Schizosaccharomyces pombe, where it was found that the hexokinase enzyme was insensitive to T6P40,43. In contrast, from our results, it seems that the C. auris hexokinase enzyme is still sensitive to T6P, suggesting a species-specific divergence in glucose metabolism. One possible explanation is that C. auris exhibits a lower glucose uptake rate relative to S. cerevisiae and C. glabrata, thereby limiting intracellular glucose accumulation and preventing the accumulation of metabolic intermediates to harmful levels. A reduced glucose influx would allow for a more balanced glycolytic flux, mitigating the risk of metabolic dysregulation and enabling normal growth under glucose-repleted conditions. This suggests that the regulatory role of T6P in glycolysis may be less critical in C. auris, potentially due to inherent differences in glucose transporter expression, hexokinase regulation, or broader metabolic network architecture. Further comparative studies on glucose uptake kinetics and central carbon metabolism in C. auris and related fungal pathogens will be necessary to confirm this hypothesis and elucidate the underlying mechanisms of metabolic resilience in this emerging pathogen. It is well established that trehalose plays a vital role in cellular protection in pathogenic fungi by stabilizing proteins and membranes under various stress conditions encountered during infection, including oxidative stress, osmotic stress, and heat shock44,45. Beyond its classical role as a stress protectant, emerging evidence highlights the broader regulatory functions of trehalose metabolism in different fungal physiology21,31,46–49. In line with previous observations, our findings demonstrate that trehalose metabolism plays a critical role in thermal stress tolerance in C. auris. Deletion of either TPS1, TPS2, or both genes led to varying degrees of growth impairment at elevated temperatures, with the tps2Δ strain displaying the most severe phenotype, as there is complete growth inhibition at 42 °C. These results underscore the essential role of trehalose biosynthetic enzymes in maintaining cellular fitness under heat stress conditions. Interestingly, the tps2Δ strain, despite having reduced chitin, exhibited heightened sensitivity to CFW, whereas neither the tps1Δ nor the tps1Δ tps2Δ strains showed comparable sensitivity. Classically, elevated chitin content confers CFW hypersensitivity, while reduced chitin (e.g., in a chs3Δ mutant) confers resistance50–52. Consistent with previous reports53, our data suggest that CFW sensitivity depends on chitin accessibility and overall cell-wall organization, not simply on chitin abundance. The contrasting phenotypes of tps2Δ and tps1Δ tps2Δ strains point to intracellular T6P accumulation in the tps2Δ strain as the principal driver of the cell-wall defect. This defect most likely arises from T6P-mediated perturbations of wall architecture and compromised integrity54, rather than from a simple loss of trehalose-mediated protection. In addition, the tps2Δ strain also displayed an increased resistance to CR stress, which targets β-glucan components of the cell wall. This may reflect compensatory modifications in other cell wall polysaccharides. Collectively, these stress-related phenotypes highlight the multifaceted role of trehalose metabolism in C. auris, not only in promoting thermal stress resilience but also in preserving the structural integrity and adaptive capacity of the fungal cell wall. The trehalose biosynthesis pathway has previously been proposed as a viable therapeutic target30. For example, in C. albicans, deletion of the TPS1 gene significantly reduced cell survival following amphotericin B treatment, although susceptibility to fluconazole remained unaffected55. Similarly, in C. glabrata, the tps2Δ strain exhibited increased sensitivity to fluconazole, attributed to the loss of trehalose-mediated protection of cellular proteins and membranes under drug-induced stress conditions31. In our study, deletion of the TPS2 gene in C. auris led to markedly increased sensitivity to all echinocandin drugs (caspofungin, micafungin, and anidulafungin). This enhanced susceptibility was evidenced by a reduction in MICs, as well as a substantial decrease in tolerance, reflected by impaired growth and survival at supra-MIC concentrations after 48 hours of incubation. Here, “supra-MIC” refers to antifungal concentrations that exceed the MIC, the lowest drug concentration necessary to inhibit visible microbial growth. The decreased ability to survive under these higher drug concentrations further highlights the importance of the targeted pathway in antifungal stress tolerance. Furthermore, we validated Tps2 as a potential antifungal target in a murine model of systemic candidiasis. While caspofungin treatment had minimal impact on fungal burden in mice infected with the WT strain, it resulted in a significant reduction54 in fungal load in both the kidneys and brain of mice infected with the tps2Δ strain. These results support the therapeutic potential of Tps2 inhibition as part of a combination strategy with echinocandins. Notably, deletion of the TPS2 gene did not alter susceptibility to azoles or polyenes, suggesting a degree of specificity in the drug-sensitizing effect and further underscoring the potential of targeting trehalose metabolism in antifungal therapy. Echinocandin resistance and tolerance in fungal pathogens are often mediated by compensatory mechanisms, such as the upregulation of chitin synthesis to counteract β-glucan disruption in the cell wall56,57. In our study, among the genes examined, only GFA1—which encodes the rate-limiting enzyme of the hexosamine pathway—was upregulated in the tps2Δ background. We initially hypothesized that loss of Tps2 and consequent T6P accumulation might directly impair Gfa1 activity, thereby reducing chitin synthesis and weakening cell-wall integrity. To test this, we constructed a gfa1Δ strain. As expected, gfa1Δ required exogenous glucosamine for growth. In the presence of low amounts of glucosamine, the gfa1∆ strain showed markedly reduced caspofungin resistance and tolerance, which were only partially improved by increasing glucosamine and did not return to WT levels. These observations argue against a model in which T6P directly inhibits Gfa1. Instead, the upregulation of the GFA1 gene in the tps2Δ strain likely reflects a negative feedback mechanism regulated by intracellular UDP-GlcNAc, whereby elevated GFA1 gene expression partially counteracts this feedback to expand the UDP-GlcNAc pool in order to provide additional substrate for chitin synthesis. In addition, transcript profiling of the four putative chitin synthase genes in the tps2Δ strain revealed reduced gene expression of CHS1 and CHS2, whereas CHS3 and CHS8 were unchanged. The functions and regulatory hierarchy of the C. auris CHS paralogs remain undefined. However, in S. cerevisiae and C. albicans the class IV enzyme Chs3 produces most cell-wall chitin, while Chs1 and Chs2 play more specialized roles (e.g., repair and septum formation)58–63. Accordingly, the decrease in CHS1/CHS2 transcripts in tps2Δ should not be over-interpreted as evidence of a global loss of chitin-biosynthetic capacity. Rather, the reduced chitin content likely reflects altered precursor supply (UDP-GlcNAc flux), post-transcriptional regulation, or defects in enzyme activation/trafficking, rather than transcriptional down-regulation of CHS genes alone. Future work should include functional characterization of C. auris chitin synthases—such as enzymatic assays and analysis of Chs3 localization under trehalose/T6P perturbation—to resolve these possibilities. Studies in S. cerevisiae have shown that elevated T6P levels can interfere with cell wall integrity by modulating the activity of enzymes involved in chitin biosynthesis64. Similarly, in C. albicans, deletion of the TPS2 gene leads to T6P accumulation, resulting in stress sensitivity and alterations in cell wall composition65. T6P is known to inhibit hexokinase36, the first enzyme in glycolysis, thereby reducing the availability of F6P, an essential precursor for the chitin biosynthetic pathway via Gfa139. Further supporting a conserved mechanism, studies in Aspergillus nidulans revealed that disruption of orlA, the ortholog of TPS2, high T6P accumulation leads to compromising cell wall architecture66. These observations suggest a conserved role for T6P accumulation in compromising cell wall architecture across diverse fungal species. Drawing upon these findings, we hypothesized that T6P accumulation in the tps2Δ strain of C. auris may similarly impair chitin biosynthesis by disrupting glycolytic flux and precursor availability (Supplementary Fig. S5). To test this hypothesis, we assessed hexokinase activity in the tps2Δ strain and evaluated glucose metabolic flux to determine whether impaired glycolysis contributes to the observed defects in cell wall integrity and antifungal susceptibility. Our enzyme activity assay and 13CNMR-based glucose metabolism analyses support this hypothesis. In the tps1Δ and tps1Δ tps2Δ strains, we observed a significant increase in hexokinase activity, which lead to a higher glycolytic rate, as indicated by increased glucose consumption and ethanol production. Notably, there is no effect on the levels of other glycolysis-derived metabolites such as glycerol and mannitol, suggesting that elevated hexokinase activity selectively boosts glycolysis without broadly altering associated metabolic pathways. In contrast, deletion of the TPS2 gene led to the accumulation of T6P, a known inhibitor of hexokinase. As a result, the tps2Δ strain exhibited reduced hexokinase activity, impaired glucose utilization, and significantly lower production of ethanol, glycerol, and mannitol. These findings indicate a substantial reduction in glycolytic activity, likely due to T6P-mediated inhibition of glucose entry into the pathway. As illustrated in Supplementary Fig. S5, the majority of intracellular glucose in fungal cells is processed through glycolysis, while a smaller fraction (~6%) of F6P is diverted into the hexosamine biosynthesis pathway (HBP) to generate UDP-GlcNAc, an essential precursor for chitin synthesis38,67. Therefore, reduced glycolytic flux in the tps2Δ strain likely limits the availability of F6P for the HBP, thereby impairing chitin biosynthesis. C. auris, similar to other Candida species, is capable of mounting a compensatory increase in cell wall chitin in response to echinocandin treatment at sub-inhibitory concentrations. This adaptive response is a well-established mechanism of echinocandin tolerance, as it helps maintain cell wall integrity when β-1,3-glucan synthesis is impaired. Notably, Lara-Aguilar et al. (2021) demonstrated that C. auris exhibits a significant increase in chitin content following exposure to high concentrations of caspofungin68. Although this response is less pronounced compared to C. albicans, it supports the presence of a conserved, stress-induced chitin remodeling mechanism in C. auris that contributes to survival under echinocandin pressure. Hence, we asked whether deletion of the TPS2 gene alters the compensatory chitin response to echinocandin stress. Sub-MIC concentrations of caspofungin increased chitin content in WT cells, and a similar increase occurred in the tps2Δ strain (Supplementary Fig. S6). Thus, caspofungin-induced chitin upregulation appears largely independent of Tps2, suggesting that the primary defect in the tps2Δ strain lies in metabolic precursor supply rather than in activation of the compensatory cell-wall stress program. To further test whether impaired chitin synthesis could be rescued by bypassing the glycolytic bottleneck, we supplemented the growth medium with exogenous glucosamine, which can be directly converted intracellularly into glucosamine 6-phosphate, a key intermediate in chitin biosynthesis. As shown in Fig. 9, BDA and Etest results demonstrated that increasing concentrations of exogenous glucosamine progressively restored caspofungin resistance and tolerance in the tps2Δ strain. This supports the hypothesis that reduced chitin content, rather than an inherent increase in drug susceptibility, is the primary determinant of echinocandin sensitivity in this mutant. In conclusion, our results highlight Tps2 as a promising therapeutic target in C. auris and suggest that interfering with trehalose metabolism is an effective strategy to increase the pathogen’s sensitivity to echinocandin treatment. This sensitivity likely reflects the important role of Tps2 in both stress tolerance and virulence in many fungal species19,69. Like in C. albicans, deletion of Tps2 leads to several defects, including increased sensitivity to heat and oxidative stress65. In C. glabrata, Tps2 is required for survival under high temperature and osmotic stress31. Notably, TPS2 gene disruption leads to a strong reduction in virulence in both C. neoformans and C. albicans. For example, the TPS2 gene deletion mutant of C. albicans shows significantly reduced virulence in mouse models, while the C. neoformans TPS2 gene deletion mutant cannot grow at 37 °C and is therefore unable to survive in mammalian hosts19,49,54,70. Although phosphatases are often considered challenging drug targets due to risks of off-target activity and poor selectivity, fungal Tps2 appears to be an exception30. Biochemical studies have shown that Tps2 is highly specific for T6P and shows no activity toward other sugar phosphates or general phosphatase substrates71. This strong specificity reduces the likelihood of unintended effects and supports its potential as a safe drug target. Taken together, our findings provide a strong foundation for developing new antifungal treatments that target Tps2 in C. auris, a multidrug-resistant pathogen of growing concern. Screening chemical libraries or designing new inhibitors that block Tps2 activity, especially in combination with existing echinocandin drugs, could significantly improve treatment outcomes. Given that trehalose biosynthesis is conserved across many fungal pathogens, this approach may also have broader applications in the fight against invasive fungal infections. Methods Strains and growth conditions The parental strains used in this study were single colony isolates from clinical strains of Pakistan (Clade I)8, South Africa (Clade III)8, Colombia (Clade IV)72 and Iran (Clade V)73. The strain ID information of each parental strain is listed in Supplementary Data 1. Strains were stored at − 80 °C in 20% glycerol and routinely cultured on solid YPD agar (1% yeast extract, 2% bacteriological peptone, 2% dextrose and 2% agar) at 37 °C. Unless otherwise stated, C. auris cells were cultured in 5 mL of RPMI 1640 with L-glutamine (Sigma-Aldrich, Saint Louis, MO, USA) buffered with 0.165 M morpholine propane sulfonic acid (MOPS) to pH 7 and supplemented with 2% glucose. Cultures were incubated at 37 °C in a shaking incubator set at 250 rpm. During the transformations, nourseothricin (NAT) (WERNER BIO) was added to the medium to a final concentration of 200 µg/mL to select for cells which contained the NAT marker. Plasmid construction Plasmids were propagated in E. coli TOP10F′ chemically competent cells. Bacterial transformation was performed by heat shock at 42 °C for 45 s using 30 µL of competent cells, followed by incubation on ice for 2 min. Transformants were selected on LB agar (LB powder, Sigma or Fisher Scientific; 1.5% [w/v] Bacto™ Agar, BD) supplemented with ampicillin (100 µg/mL). To generate the deletion mutants, we employed the SAT1 flipper system74. Specifically, the upstream and downstream regions of the target genes (TPS1, TPS2 and GFA1) were amplified from the genomic DNA of C. auris strain B8441. These regions were directionally cloned into the pSFS2 vector in a homodirectional way74, flanking the NAT marker and the gene encoding recombinase. The upstream regions were inserted into ApaI/XhoI digested pSFS2 using NEBuilder HiFi DNA Assembly, following the manufacturer’s protocol. The resulting constructs were isolated from the transformants, digested with SacII and NotI-HF, and the downstream regions were subsequently cloned into the prepared plasmids. All inserts of the plasmids were verified by sequencing (Mix2Seq, Eurofins Genomics) to confirm correct integration. All plasmids used in this paper listed in using the primers listed in Supplementary Data 1. Finally, linear deletion cassettes were produced by digesting each plasmid with KpnI-HF/BglI (NEB). Strain construction and gene deletion Trehalose metabolism deletion mutants were generated in C. auris strains B8441(Clade I, WT), B1122 (Clade III), B11244 (Clade IV) and IFRC2087 (Clade V) background strains. They were initially cultured overnight in YPD medium at 37 °C with shaking. The overnight culture was then diluted to OD600 0.4 and grown until reaching an OD600 1.5–2.0. Cells were harvested by centrifugation (3500 x g, 5 mins) and resuspended in transformation buffer (1 x TE buffer, and 100 mM lithium acetate (LiAc)), followed by incubation at 37 °C for 1 h with shaking. Subsequently, 1 M dithiothreitol (DTT) was added, and cells were incubated for an additional 30 min. The cells were then washed with ice-cold distilled water and 1 M sorbitol and finally resuspended in 1 M sorbitol to prepare competent cells. Transformation was performed via electroporation using a transformation mixture containing Alt-R™ S.p. Cas9 Nuclease V3, duplexed gene-specific Alt-R® CRISPR-Cas9 crRNA (IDT) with Alt-R® CRISPR-Cas9 tracrRNA (IDT), gene-specific guide RNA (gRNA) (IDT), and the linearized constructed pSFS2 variant for each gene as donor DNA. Following electroporation, cells were incubated in YPG (3% glycerol) recovery medium and subsequently plated onto YPG agar supplemented with NAT for selection. Successful gene deletions were verified by colony PCR using primers flanking the upstream and downstream target gene regions. Details of the primer sequences and crRNA design are provided in using the primers listed in Supplementary Data 2. For double gene deletion, verified single-gene deletion transformants were cultured overnight in YP medium containing maltose at 37 °C to induce excision of the NAT resistance cassette. The same transformation protocol was then used to generate the second gene deletion, following identical steps as described above. For GFA1 gene deletion, following electroporation, cells were recovered in YPD medium supplemented with 20 mM glucosamine. Following recovery, cells were plated onto YPD agar containing 20 mM glucosamine and NAT for selection of transformants. For reintegration of the TPS2 gene into the B8441 tps2Δ background, a single tps2Δ isolate was used. Deletion mutants were cultured in YPD and repeatedly streaked to obtain clones that had lost the NAT resistance cassette; cassette excision was verified by PCR. The residual FRT scar was then targeted using the episomal CRISPR–Cas9 vector pJMR19 (from Rybak lab)75, enabling scarless restoration of the native TPS2 locus without introducing permanent exogenous sequences. A donor fragment containing the TPS2 gene together with ~500 bp of upstream and downstream genomic sequence was amplified from B8441 genomic DNA and used for homologous recombination. Transformants were selected on YPD supplemented with NAT (200 µg/mL) and screened by diagnostic PCR using primers binding outside the homology arms and within the TPS2 ORF. Correct integration was confirmed by PCR across both the 5′ and 3′ junctions and subsequently by sequencing. Growth phenotype assay The growth dynamics of C. auris strains were monitored over time in liquid RPMI 1640 medium. Overnight cultures of each strain were washed three times with sterile Milli-Q water and subsequently diluted to an initial OD600 of 0.1. Then, 20 µL of the cell suspension was added to 180 µL of RPMI 1640 medium supplemented with either 0.2% or 2% glucose as the carbon source. Growth was assessed at 37 °C, 39 °C, and 42 °C by measuring OD600 every 30 min using a Multiskan FC microplate photometer (Thermo Scientific) in flat-bottom 96-well microtiter plates (Bioké). During incubation, cultures were subjected to intermittent pulsed shaking (1 min duration every 10 min at medium strength) to ensure aeration and uniform cell distribution. Data analysis was performed in Graphpad Prism version 10.4.2. Drug and stress susceptibility testing The susceptibility of C. auris strains to various antifungal agents—caspofungin, micafungin, anidulafungin, amphotericin B, and fluconazole (all sourced from Merck)—was evaluated by broth dilution assay according to guidelines provided by the Clinical and Laboratory Standards Institute (CLSI)76. In brief, antifungal agents were serially diluted two-fold in RPMI 1640 medium buffered with MOPS (pH 7.0) supplemented with 2% glucose and 1% DMSO, reaching a final assay volume of 200 µL per well. The concentration range tested was from 16 to 0.0625 µg/mL for caspofungin, micafungin, amphotericin B, and fluconazole, and from 8 to 0.03125 µg/mL for anidulafungin. Subsequently, an inoculum containing ~ 25,000 cells/mL was dispensed into round-bottom 96-well polystyrene microtiter plates (Greiner Bio-One) prior to incubation. Stress susceptibility was evaluated using the same BDA protocol. Stressor concentrations in the final assay medium were prepared in two-fold serial dilutions as followed: H2O2 (Sigma-Aldrich) at concentrations ranging from 20 mM to 0.0781 mM, CFW (Fluorescent Brightener 28, Sigma-Aldrich) at concentrations ranging from 5 mM to 0.0195 mM, and CR (Sigma-Aldrich) at concentrations ranging from 12 mM to 0.0467 mM; sodium chloride (NaCl; Sigma-Aldrich) from 2.5 M to 0.0098 M; and SDS (Sigma-Aldrich) from 3.74 mM to 0.014 mM. Plates were incubated at 37 °C for 48 h. Fungal growth was quantified by measuring OD600 using a Synergy™ H1 microplate reader (BioTek Instruments). MICs from BDA were determined based on a 50% reduction in growth relative to the drug-free control. In addition to BDA, antifungal susceptibility was also assessed using ETEST® strips (bioMérieux), following the manufacturer’s instructions. MIC values were defined by the point at which the ellipse of inhibition intersected the scale on the strip after 48 h of incubation at 37 °C. Determination of intracellular trehalose levels Exponentially grown cells were harvested by centrifugation 3500 x g (4 °C) for 5 min. The supernatant was discarded, and the cells were resuspended in 1 mL ice cold Milli-Q water. Next, they were broken by vigorously vortex in the presence of glass beads (0.75-1 mm) by means of the FastPrep (20 s, 6 m/s) (MP biomedical™). Then, immediately transferred to a 95 °C water bath for 5 min. Afterwards, the sample was centrifuged at 7000 x g (4 °C) for 5 min and 200 µL of the supernatant was used for analysis by the Shimadzu HPLC system using an Agilent 87 H column at 0.7 mL/min and a RID−20A detector (Shimadzu). 1 mM sulfuric acid was used as eluent at a constant flow of 0.6 mL/min at 80 °C. Pure trehalose (Sigma) was used as a standard. Determination of intracellular T6P levels Intracellular T6P levels was measured according to Zhu et al., 202531. Exponentially grown cells were harvested by centrifugation at 3000 x g (4 °C) for 5 min. Weigh as quickly as possible to get an aliquot in the range of 15-20 mg (wet weight). The cells were extracted as described in Lunn et al. with a little modification77. Briefly, cells were rinsed with 175 µL ice-cold CHCl₃/MeOH (3:7) and incubated at − 20 °C for 2 h with occasional vortexing; add 350 µL ice-cold water was added, vortexed ≥ 5 s to disperse phases, warmed to 4 °C with intermittent shaking, then centrifuged at 13,000 × g, 4 °C for 10 min. The upper aqueous/MeOH layer was transferred to a new 1.5 mL screw-cap tube on ice; the lower CHCl₃ phase was re-extracted with 300 µL ice-cold water, vortexed and centrifuged as above, and the upper layers were pooled and dried completely in a vacuum centrifuge at 35 °C. T6P was assayed in extracts by anion-exchange HPLC using a Dionex HPLC system (Sunnyvale, CA, U.S.A.), coupled to an AB Sciex Q-Trap 6500 triple quadrupole mass spectrometer with modifications as described in Figueroa et al. 201678. RNA Extraction and gene expression analysis For total RNA isolation, cells were grown overnight and diluted to an OD600 of 0.2 in RPMI 1640 (2% glucose). Cells were grown for 5–7 h and afterwards washed ice-cold water, resuspended in 0.5-1 mL TRIzol (ThermoFisher) and broken by using glass beads in a FastPrep machine. RNA was extracted by the addition of chloroform and isopropanol after which three washes with ethanol (70 %) were conducted. RNA was treated with DNase enzyme (New England Biolabs) and converted to cDNA using the iScript cDNA synthesis kit (Biorad). qPCR was conducted using GoTaq polymerase (Promega) and the StepOnePlus real-time PCR device (ThermoFisher). Primers used are listed in supplymentary data 2. ACT1, UBC13 and RPL10 were used as reference genes. Data were subsequently analyzed using qBasePlus software (Biogazelle)79. Fluorescence Microscopy to Quantify Cell Wall Components Cells were fixed in 50 mM Thimerosal at room temperature for 24 h, washed twice in water, and resuspended in 1 mL water. For β-glucan and chitin staining, approximately 2.5 × 106 cells were incubated with the anti-β-glucan primary antibody Fc-Dectin-1 (ThermoFisher) (1.5 µg/mL) for 45 min at room temperature, followed by incubation for 30 min in the dark with a PBS solution containing GT F(ab’)2 anti-human IgG secondary antibody conjugated to Alexa Fluor 488 (1:200 dilution) (ThermoFisher) for staining β-glucan and Calcofluor White (25 µg/mL) for staining chitin. For mannan staining, 2.5 × 106 cells were separately incubated for 30 min in the dark with a PBS staining solution containing Concanavalin A-Alexa Fluor 488 (ThermoFisher)(25 µg/mL). After staining, cells were washed once in water and resuspended in water for analysis. For microscopy, 5 µL aliquots were mounted on glass slides, air-dried, and visualized using confocal microscopy with a DAPI filter set, following the method previously described by Okada and Ohya80. Sub-MIC Caspofungin Treatment and Chitin Staining Overnight cultures were washed three times with sterile Milli-Q water, diluted to an initial OD600 of 0.2, and grown in RPMI 1640 supplemented with 2% glucose with the indicated sub-MIC concentrations of caspofungin at 37 °C for 5-7 h with shaking (200 rpm). Cells were washed three times with 1 x PBS and fixed in 4% paraformaldehyde (ThermoFisher Scientific) at 37 °C for 30 min. Fixed cells were washed three times with 1 x PBS, stained in the dark with CFW (10 µg/mL) at RT for 30 min, washed three additional times with 1 x PBS, and imaged by confocal microscopy as above. Methods follow our previously described protocol of Fluorescence Microscopy to Quantify Cell Wall Components. Chemical quantification of cell wallcomponents Cell walls from isolates were prepared from exponentially growing cultures in RPMI 1640 supplemented with 2% glucose, following the method described by Munro et al. (2003)81, with minor modifications. Briefly, cell walls (20 mg wet weight) were extracted by disrupting cells with glass beads in a FastPrep machine. Samples were washed five times with 1 M NaCl, and cell walls were extracted using SDS-Mer-OH buffer (50 mM Tris, 2% SDS, 0.3 M β- mercaptoethanol, 1 mM EDTA; pH 8.0) at 100 °C for 10 minutes. Cell wall pellets were resuspended in sterile Milli-Q water, freeze dried, and the dry weight of recovered cell walls was measured. Chitin contents were determined by measuring the glucosamine. For glucose and mannose measurement, hydrolysates were diluted 100 times (10 µL hydrolysate in 1 mL of 2 M NaOH) and further diluted 10 times with Milli-Q water in a glass vial for analysis. Fifteen µL was analyzed by high-performance anion-exchange chromatography with integrated pulsed amperometric detection (HPAEC-iPAD) (ICS−3000, Dionex, Sunnyvale, CA, USA) equipped with a CarboPac MA1 Guard column (50 × 4) in series with a CarboPac MA1 column (250 ×4). The sugars were isocratically separated with 600 mM NaOH with a flow rate of 400 µL/min of 600 mM NaOH during 24 min. Quantification was performed on peak areas with external standards of glucose and mannose82,83. Hexokinase activity measurement Hexokinase activity was measured according to Wijnants et al., 2020 with small adaptations83. Cells were grown at 37 °C in RPMI 1640 (2% glucose). They were collected and washed twice with 1 x imidazole buffer (50 mM, pH 7.5, 10 mM MgCl₂, 100 mM KCl, and 0.1 mM EDTA). The cell pellet was resuspended in 1 x imidazole buffer to a final concentration of 200 mg cells/mL. Cells were lysed by FastPrep (20 s, 6 m/s) for 10 times (place on ice for 30 seconds between each time) and a protease inhibitor cocktail (complete, EDTA free; Roche) was added to prevent proteolysis. The supernatant was collected after centrifugation at 3000 x g (4 °C). Hexokinase activity was measured spectophotometrically at 340 nm every 30 s for 10 min by coupling to the reduction of NADP+ via glucose-6-phosphate dehydrogenase. The reaction contained 2 x imidazole buffer, 50 mM ATP, 40 mM NADP, 0.6 U glucose-6-phosphate dehydrogenase (G6PDH; Sigma), 2 U phosphoglucose isomerase (PGI; only in the fructose buffer; Sigma), and 0.1% glucose and 20 µL of cell extract. The protein concentration was measured by the Lowry method82. 13C NMR Spectroscopy Utilization of 13C-labeled glucose ([1−13C] glucose and [u-13C6] glucose, both Cambridge Isotope Laboratories (Andover, MA, USA)) was monitored by 13C NMR spectroscopy similar to a previously described study84. In brief, cells were cultured in RPMI 1640 medium containing 2% glucose at 37 °C for 5–6 hours. Following incubation, the cells were harvested and washed twice with 1 x PBS. They were then resuspended at a concentration of 10⁷ cells/mL in glucose-free RPMI 1640 medium supplemented with MOPS buffer and kept on ice until further use. For NMR spectroscopy, cell suspensions (0.4 mL) were transferred to 5 mm NMR tubes (Eurisotop, St. Aubin, France), heated up to 37 °C for 5 min and then 0.1 mL deuterated water (Eurisotop) containng 13C labeled glucose (final concentration 100 mM) was added. NMR tubes were transferred to the NMR spectrometer and a time series of NMR spectra was acquired within 5 min (n = 3-4 per strain). NMR spectra were acquired at 37 oC using a Bruker Avance 400 MHz NMR spectrometer (Bruker Biospin, Rheinstetten, Germany), equipped with an 5 mm broadband probe. After the acquisition of a 1H NMR spectrum (total acquisition time 1:30 minutes), 3 or 6 13C NMR spectra with 256 averages (total acquisition time 15 minutes) followed by 6 or 3 13C NMR spectra with 512 averages (total acquisition time 30 minutes) and a final 13C NMR spectrum with 1024 averages (total acquisition time 60 min) were acquired, covering a period of up to 4.5 h. Other acquisition parameters were: frequency 100.63 MHz, relaxation time 2 s, acquisition time 1.5 s, spectral width 22 000 MHz, 64 k data points, proton decoupling using a WALTZ16 sequence. All NMR spectra were processed and quantified using the Bruker software TopSpin 3.2. Relative quantification of 13C labeled metabolites was achieved after phase and baseline correction, setting the total integral of the alpha and beta C-1 glucose signals in the first 13C NMR spectrum to 100%. In vivo experiments For the in vivo experiments, 7-week-old BALB/c female mice were used (Janvier Labs), kept per three in individually ventilated cages. We acknowledge sex as a biological variable and discuss this as a limitation. Food and water were available ad libitum. For immunosuppression, cyclophosphamide (CP) was administered via intraperitoneal (IP) injection at a dosage of 200 mg/kg 3 days prior to infection and 150 mg/kg the day after the infection. Both CP injections had a total volume of 200 μL. Mice were infected intravenously through the tail vein with an inoculum of 10⁷ C. auris WT or tps2Δ cells in 100 μL PBS, administered separately. The animals were IP treated daily for 6 days, starting the day of infection (2 h post inoculation), with 5 mg/kg caspofungin (in a total volume of 100 μL) or the PBS as control. 7 days post infection, the mice were sacrificed and colonization in kidneys and brain was evaluated: organs were homogenized in 500 µL sterile 1 x PBS with glass beads and shaking (20 seconds at 6 m/second) in a FastPrep−24TM Classic lysis system (MP Biomedicals). The organ homogenates were serially diluted and plated onto YPD agar for single colony (CFU) isolation after 48 h incubation at 37 °C. Statistics & reproducibility The figure legends detail statistical parameters, including the exact sample size (n) and measures of statistical significance. Statistical analyses were performed using GraphPad PRISM software version 10.4.2 (534) (GraphPad et al., LLC). The specific statistical tests applied are also described in the figure legends. Ethical statement All animal experiments were approved in accordance with the ethical guidelines of the Ethical Committee for Animal Experimentation of KU Leuven (project number: 079/2020) and were performed in accordance with the regulations of the KU Leuven animal care guidelines. The KU Leuven ethical committee for animal experimentation is part of the regional regulations imposed by the Flemish government, Secretary General of the Unit Animal Welfare, ‘Departement Leefmilieu, Natuur & Energie’, Koning Albert II-laan 20 bus 8, 1000 Brussel. All mice were kept in filter-top cages in an animal room with controlled temperature (21 °C), humidity (50% ~ 70%), and 12 h light/12 h dark cycle. Reporting summary Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Supplementary information Supplementary Information Description of additional supplementary files Supplementary data set 1 Supplementary data set 2 Reporting summary Transparent Peer Review file Source data Source data Acknowledgements This work was supported by grants from the Fund of Scientific Research Flanders (FWO # G0C0622N to P.V.D. and #G067023N to U.H.) and by the Max Planck Society (R.F. and J.E.L.). Q.Z. acknowledges the Overseas Study Program of Guangzhou Elite Project (nr: S.J. [2020] No. 2) for a PhD fellowship. H.C. was supported by a post-doctoral fellowship granted by KU Leuven Internal Funds (PDMT2/23/032) and the European Molecular Biology Organization - EMBO (ALTF 1105-2024). D.S., S.J., and S.W. are supported by personal PhD or postdoc grants from the Fund of Scientific Research Flanders (FWO grants #11J8122N, #11PRR23N and #1271225, respectively). Author contributions Q.Z. conceived the study, designed and performed experiments, analyzed the data, and wrote the manuscript. S.V.V. performed the BDA drug assays. R.V. assisted with sterol profiling and analysis. J.E.L. and R.F. assisted with trehalose 6-phosphate quantification and analysis. O.V.G., D.S., and S.J. assisted with animal experiments. W.V.E. and R.V. assisted with cell-wall component measurements. J.M.R. provided plasmids for reintegration strain construction. U.H. performed 13C NMR experiments and data analysis. W.V.G., H.C., and P.V. provided conceptual input. P.V.D. and S.W. supervised the study, revised the manuscript and provided funding. All authors reviewed and/or approved the final manuscript. Peer review Peer review information Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work. A peer review file is available. Data availability The authors declare that the data supporting the findings of this study are available within the article and its Supplementary Information files. Parental strains of C. auris are available via the CDC & FDA Antibiotic Resistance Isolate Bank (https://wwwn.cdc.gov/arisolatebank/). All strains generated in this study will be made available upon request from authors. Source data are provided in this paper. Competing interests All authors read and approved the manuscript. The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary information The online version contains supplementary material available at 10.1038/s41467-025-67022-x. References Associated Data Supplementary Materials Supplementary Information Description of additional supplementary files Supplementary data set 1 Supplementary data set 2 Reporting summary Transparent Peer Review file Source data Data Availability Statement The authors declare that the data supporting the findings of this study are available within the article and its Supplementary Information files. Parental strains of C. auris are available via the CDC & FDA Antibiotic Resistance Isolate Bank (https://wwwn.cdc.gov/arisolatebank/). All strains generated in this study will be made available upon request from authors. Source data are provided in this paper.